<?xml version="1.0" encoding="UTF-8"?>
<p id="par0170">In addition, although still in use, many CADs are associated with liver toxicity and cardiotoxicity in terms of arrythmia caused by QT interval prolongation [
 <xref rid="bib0135" ref-type="bibr">27</xref>,
 <xref rid="bib0140" ref-type="bibr">28</xref>], and thus we have added to our analysis known data on these adverse effects. Liver toxicity evaluation is taken from the LiverTox database (where A levels indicates the highest likelihood of liver toxicity, and E the lowest) [
 <xref rid="bib0180" ref-type="bibr">36</xref>]. For cardiotoxicity, we have marked positive (orange) if there is a reported effect of the compound on either QT interval prolongation/arrhythmia in humans or a positive result in 
 <italic>in vitro</italic> hERG assay.
</p>
